Search for: "McNeil v McNeil" Results 401 - 420 of 568
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Oct 2008, 7:12 pm
If so click here to arrange your free consultation with Victoria ICBC injury claims lawyer Erik Magraken (with associated offices in Victoria, Nanaimo, Kelowna, Port Hardy, Kamloops, Duncan, Courtenay, Qualicum Beach, Port McNeil, Tofino, Vernon, Dawson Creek, Revelstoke, Ucluelet, Salmon Arm, Castlegar, Sicamous and Nakusp) [read post]
12 Apr 2010, 1:58 pm by MacIsaac
Examples of such cases are Fellowes, McNeil v. [read post]
27 May 2010, 3:20 am
(Patent Docs) Levaquin (Levofloxacin) – US: When it comes to patent term extensions, an enantiomer is a different drug from racemate: Ortho-McNeil Pharma v. [read post]
17 Feb 2012, 11:29 am by Bexis
Ortho-McNeil-Janssen Pharmaceuticals Inc., 2010 WL 3548474 (Pa. [read post]
1 Mar 2013, 2:30 pm by Bexis
McNeil-PPC, Inc., 2009 WL 1178651, at *3-4 (Pa. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
7 Apr 2010, 4:30 am
– Myriad stock prices: Association of Molecular Pathology v USPTO (Innovationpartners) US: Federal judge in Myriad patent case says invalidation of gene patents does not violate TRIPS: Association of Molecular Pathology v USPTO (KEI) US: ACLU gene patent decision from an investor’s perspective: A black eye for the US patent system: Association of Molecular Pathology v USPTO (Holman's Biotech IP Blog) US: Association of Molecular Pathology v USPTO:… [read post]